GlassScriptPhysician profile
Luke Pesonen
NPI 1689092652
$3,896.30
in general payments reported to CMS, 2019-2025
7 companies · $1,417 in 2025
The $1,417 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $981 · 2021: $474 · 2022: $402 · 2023: $114 · 2024: $159 · 2025: $1,417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $846 · Food and Beverage: $844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $846.18 |
| Food and Beverage | $844.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,842.07 | 2022-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Medtronic Vascular, INC. | $1,329.81 | 2019-2020 | |
| Medtronic, INC. | $342.06 | 2021-2023 | Venaseal |
| Abbott Laboratories | $191.80 | 2021 | |
| Silk Road Medical, INC. | $65.61 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Shockwave Medical, INC | $64.00 | 2025 | |
| Terumo Medical Corporation | $60.95 | 2022-2025 | R2p Misago, Metacross Otw |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Pesonen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.